🇫🇷 Prevnar 20 in France
Prevnar 20 (pneumococcal 20-valent conjugate vaccine (PCV20)) regulatory status in France.
Pricing & reimbursement
- List: EUR 72.00 per year
- List: EUR 72.00 per year
- List: EUR 72.00 per year
- List: EUR 72.00 per year
- List: EUR 72.00 per year
Prevnar 20 in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in France
Frequently asked questions
Is Prevnar 20 approved in France?
Prevnar 20 does not currently have French marketing authorisation in our dataset.
Who is the marketing authorisation holder for Prevnar 20 in France?
Pfizer Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.
What does Prevnar 20 cost in France?
List: EUR 72.00 per year; List: EUR 72.00 per year; List: EUR 72.00 per year; List: EUR 72.00 per year; List: EUR 72.00 per year. Final patient cost depends on reimbursement and any patient access scheme.